Table 1.
Participant characteristics.
| Variable | Patients (n = 97) | Controls (n = 104) | p-Values |
|---|---|---|---|
| Age: M (SD) | 61.62 (10.07) | 58.38 (12.44) | 0.05 |
| Race: n (%) White | 92 (96) | 92 (89) | 0.05 |
| Education: n (%) college graduate | 33 (34) | 74 (71) | <0.0001 |
| Income: n (%) USD 40,000 or more | 51 (68) | 73 (81) | 0.05 |
| Comorbidities: M (SD, range) | 2.40 (0.85, 2–7) | 2.19 (0.53, 2–5) | 0.05 |
| Menopausal status: n (%) | <0.01 | ||
| Pre-menopausal | 10 (11) | 26 (25) | |
| Post-menopausal | 84 (89) | 78 (75) | |
| Cancer Type: n (%) | - | - | |
| Cervical | 1 (1) | ||
| Fallopian | 3 (3) | ||
| Ovarian | 49 (51) | ||
| Vulvar | 1 (1) | ||
| Endometrial | 35 (36) | ||
| Peritoneal | 5 (5) | ||
| Other | 2 (2) | ||
| Stage: n (%) | - | - | |
| 1 | 18 (20) | ||
| 2 | 9 (10) | ||
| 3 | 48 (53) | ||
| 4 | 16 (18) | ||
| Prior lines of chemotherapy: n (%) 3 or more | 9 (9) | - | - |